1. PWE-095 Cost effectiveness of rifaximin-α 550 mg (xifaxan®/targaxan®) in the reduction of recurrence of overt hepatic encephalopathy in united kingdom. (22nd June 2015) Authors: Berni, E; Poole, CD; Conway, P; Radwan, A; Currie, CJ Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PWE-153 Cost Effectiveness Of Rifaximin-a In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy. (9th June 2014) Authors: Poole, CD; Conway, P; Nanuwa, K; Joseph, B; Bannister, C; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTU-126 Mortality Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease. (9th June 2014) Authors: Morgan, CL; Jenkins-Jones, S; Radwan, A; Conway, P; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-154 The First Evaluation Of The Relationship Between The Chronic Liver Disease Questionnaire And The Eq-5d Index In Hepatic Encephalopathy Patients Treated With Rifaximin-a. (9th June 2014) Authors: Berni, E; Bannister, C; Poole, CD; Conway, P; Nanuwa, K; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PTU-127 Resource Use Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease. (9th June 2014) Authors: Orr, J; Morgan, CL; Hudson, M; Jenkins-Jones, S; Conway, P; Radwan, A; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Issue 4 (29th August 2007) Authors: Currie, C J; Poole, C D; Conway, P Journal: Heart Issue: Volume 94:Issue 4(2008) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pseudosleep events in patients with psychogenic non-epileptic seizures: prevalence and associations. Issue 7 (16th June 2004) Authors: Duncan, R; Oto, M; Russell, A J C; Conway, P Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 75:Issue 7(2004) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗